Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001208710-09-000001
Filing Date
2009-09-23
Accepted
2009-09-23 14:48:36
Documents
1
Period of Report
2009-08-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2119
  Complete submission text file 0001208710-09-000001.txt   4046
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 609 GRANVILLE STREET, STE. 880 VANCOUVER A1 V7Y 1G5
Business Address
MOORE TRACY A (Reporting) CIK: 0001208710 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27239 | Film No.: 091082548